Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options

17 Oct 2017 09:10

RNS Number : 7995T
Touchstone Innovations PLC
17 October 2017
 

17 October 2017

 

Touchstone Innovations plc

 

Grant of share options

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation. 

 

Touchstone Innovations plc (AIM: IVO, "Innovations" or "the Group") has today granted options over ordinary shares in the capital of the Group ("Award Shares") to the following PDMRs under its 2016 Long Term Incentive Plan ("LTIP").

 

Number of Award Shares

Russ Cummings

315,515

Nigel Pitchford

94,827

Tony Hickson

55,173

Anjum Ahmad

46,433

 

The options have an exercise price of 3 1/33 (three and one thirty-third) pence per Award Share and are exercisable in three equal tranches during the six month periods commencing on 1 December 2020, 1 December 2021 and 1 December 2022 respectively, subject to certain performance conditions having been satisfied.

 

This grant of options is part of the Company's long-term incentive arrangements designed to align the interests of the shareholders and executives.

 

The LTIP was approved by shareholders of the Company at an annual general meeting on 21 November 2016 and was adopted by the Board on the same day. The LTIP provides for options to acquire ordinary shares to be granted to eligible employees. The arrangements are described more fully in the Directors' Remuneration Report in the Group's 2016 Annual Report, a copy of which is available on the Group's website (www.touchstoneinnovations.com).

 

For further information please contact:

 

Touchstone Innovations plc

020 3053 8834

David Newlands, Chairman

William Rayner, Company Secretary

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russ Cummings

 

2.

Reason for the notification

a)

Position / status

CHIEF EXECUTIVE OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

315,515

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

nigel pitchford

2.

Reason for the notification

a)

Position / status

CHIEF INVESTMENT OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

94,827

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

TONY HICKSON

 

2.

Reason for the notification

a)

Position / status

MANAGING DIRECTOR - TECHNOLOGY TRANSFER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

55,173

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

ANJUM AHMAD

 

2.

Reason for the notification

a)

Position / status

TREASURY AND FINANCE DIRECTOR

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

46,433

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPEXFENXFEF
Date   Source Headline
30th May 20147:00 amRNSVeryan announces results on two-year Mimics study
22nd May 20147:00 amRNSYoyo closes £2.8 million seed investment round
6th May 20142:45 pmRNSHolding(s) in Company
24th Apr 20147:00 amRNSNexeon completes manufacturing facility
14th Apr 201412:00 pmRNSDirector change
3rd Apr 20143:36 pmRNSDirector's share purchase
28th Mar 20147:01 amRNSHalf Yearly Report
13th Mar 20141:04 pmRNSNotice of Results
13th Mar 20147:01 amRNSCircassia announces offer price
26th Feb 20147:40 amRNSCircassia indicative pricing notification
6th Feb 20147:03 amRNSCircassia announces intention to float
28th Jan 20147:00 amRNSAppointment of Joint Broker
7th Jan 20147:00 amRNSCell Medica achieves EU orphan drug designation
30th Dec 201310:00 amRNSFurther investment in TopiVert
18th Dec 20137:00 amRNS£5.1m funding round for Econic Technologies
17th Dec 201312:32 pmRNSResult of AGM
17th Dec 20139:00 amRNS£17.5m funding round for Crescendo Biologics
11th Dec 20137:00 amRNSIXICO launches first CE marked device
10th Dec 20137:00 amRNSSeed funding round for Cambridge spinout Aqdot
6th Dec 20137:00 amRNSGrant of share options
22nd Nov 20133:24 pmRNSOxford Immunotec trading commences on NASDAQ
20th Nov 20139:25 amRNSPulmocide receives £17m Series A funding
18th Nov 20137:00 amRNSMISSION Therapeutics receives £20m funding
16th Oct 20137:01 amRNSOxford Immunotec makes public S1 for potential IPO
16th Oct 20137:00 amRNSBoard Changes
16th Oct 20137:00 amRNSFinal Results
1st Oct 20139:00 amRNSCircassia grass allergy treatment success
26th Sep 20137:00 amRNSCell Medica opens commercial facility in Germany
23rd Sep 20137:05 amRNSIXICO expands into digital healthcare
23rd Sep 20137:00 amRNSProposed acquisition of IXICO Limited
20th Sep 20139:00 amRNSNotice of Results
12th Sep 20137:00 amRNSCircassia phase II clinical study success
10th Sep 20137:00 amRNSLeads £8m funding round in Plaxica
29th Aug 20137:00 amRNSInvestment in new mobile payments business
12th Aug 20136:01 pmRNSDirector/PDMR Shareholding
26th Jul 20138:45 amRNSPortfolio company PolyTherics merges with Antitope
17th Jul 20137:00 amRNSDirectorate Change
2nd Jul 20137:00 amRNS£30m loan from EIB for healthcare investment
25th Jun 20137:00 amRNSInvestment in PsychologyOnline
4th Jun 20137:00 amRNSAutifony starts phase I trial
8th May 20137:00 amRNSCell Medica treats first patient in new trial
29th Apr 20137:00 amRNSInvestment team appointment
17th Apr 20139:26 amRNSBoard change
22nd Mar 20137:00 amRNSHalf year results
1st Mar 20139:22 amRNSNotice of Results
1st Mar 20138:38 amRNSNotification of major interest in shares
25th Feb 20137:00 amRNSCircassia's cat allergy treatment
14th Feb 20137:00 amRNSInvestment in new technology company
23rd Jan 20137:00 amRNS£1.5m investment in new software portfolio company
21st Jan 20133:45 pmRNSListing of shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.